Business
Bell Potter just upgraded the target price on ASX healthcare stock
Image source: Getty Images
Broker Bell Potter has issued a new report on ASX healthcare stock Neuren Pharmaceuticals Ltd (ASX: NEU).
It has maintained its buy rating and also increased its target price.
Neuren Pharmaceuticals is a biopharmaceutical company specialising in developing new…
Continue Reading
-
Noosa News23 hours agoBondi Beach terror attack: Police investigate threat against Westfield North Lakes in Queensland
-
General24 hours agoSea search for missing Victorian man off Cape Jaffa ends
-
Noosa News23 hours agoLucky few Zone RV customers rejoice after receiving caravans from collapsed manufacturer
-
General23 hours agoGold, iron ore and population swell big state’s coffers